Cargando…
New strategy for suppressing the growth of lung cancer cells harboring mutations in the ATP‐binding region of EGFR by targeting the molecular motor MYO1D
Autores principales: | Ko, Yoo‐Seung, Kang, Hyuno, Bae, Jeong A, Kim, Sung Jin, Kim, Nacksung, Chung, Ik Joo, Moon, Kyung‐Sub, Rho, Jin Kyung, Kim, Hangun, Ha, Hyung‐Ho, Oh, In‐Jae, Kim, Kyung Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343539/ https://www.ncbi.nlm.nih.gov/pubmed/34459138 http://dx.doi.org/10.1002/ctm2.515 |
Ejemplares similares
-
Geijigajakyak decoction inhibits the motility and tumorigenesis of colorectal cancer cells
por: Lee, Soong-in, et al.
Publicado: (2016) -
A new KSRP-binding compound suppresses distant metastasis of colorectal cancer by targeting the oncogenic KITENIN complex
por: Bae, Jeong A, et al.
Publicado: (2021) -
Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL
por: Kim, Yeong-Jin, et al.
Publicado: (2019) -
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
por: Park, Keunchil, et al.
Publicado: (2021) -
KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
por: Varlı, Mücahit, et al.
Publicado: (2023)